(19)
(11) EP 3 924 973 A1

(12)

(43) Date of publication:
22.12.2021 Bulletin 2021/51

(21) Application number: 20754956.9

(22) Date of filing: 14.02.2020
(51) International Patent Classification (IPC): 
G16B 25/00(2019.01)
C12Q 1/6813(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6883; C12Q 2600/158; G16B 40/20; G16B 20/00
(86) International application number:
PCT/US2020/018297
(87) International publication number:
WO 2020/168196 (20.08.2020 Gazette 2020/34)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.02.2019 US 201916276420

(71) Applicants:
  • University of North Texas Health Science Center at Fort Worth
    Fort Worth, TX 76107 (US)
  • Board of Regents, The University of Texas System
    Austin, TX 78701 (US)

(72) Inventors:
  • O'BRYANT, Sid, E.
    Aledo, TX 76008 (US)
  • BARBER, Robert, C.
    Benbrook, TX 76126 (US)
  • XIAO, Guanghua
    Coppell, TX 75019 (US)
  • GERMAN, Dwight
    Dallas, TX 75225 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Leopoldstraße 4
80802 München
80802 München (DE)

   


(54) BLOOD-BASED SCREEN FOR DETECTING NEUROLOGICAL DISEASES IN PRIMARY CARE SETTINGS